Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer

Rachel Foulkes, Mohsen Ali Asgari, Anthony Curtis, Clare Hoskins

Research output: Contribution to journalReview articlepeer-review

14 Citations (Scopus)
59 Downloads (Pure)


Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and survival is extremely unlikely. It is an extremely under-represented cancer in the research field because of the dense tumors formed and complexities surrounding treatment requirements. The use of nanomedicines in cancer therapy has been explored over the past few decades. Such nanomedicines are slowly coming to fruition in the clinical setting. One such platform that may possess promise in the fight against pancreatic cancer is the use of colloidal silver. Silver nanoparticles have shown potential in other cancer types over a host of treatment strategies, and these are likely to be translatable into pancreatic cancer. This review will focus on the potential use of silver nanoparticles in pancreatic cancer therapy, reporting on a range of different strategies being employed that may be directly applicable in the improvement of clinical outcomes for pancreatic cancer patients.
Original languageEnglish
Pages (from-to)1758-1772
Number of pages15
JournalACS Applied Nano Materials
Issue number4
Publication statusPublished - 12 Mar 2019


  • pancreatic cancer
  • silver nanoparticles
  • cancer therapy
  • thermal therapy
  • antimicrobial
  • drug delivery


Dive into the research topics of 'Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer'. Together they form a unique fingerprint.

Cite this